Originalartikel 2026

  • Schymik HS, Wrublewsky S, Hring M, Liebisch G, Both S, Gasparoni G, Bickelmann C, Robertson H, Dahlem C, Walter J, Helms V, Laschke MW, Ampofo E, Hoppstädter J, Kiemer AK. 2026. IGF2BP2 deficiency in macrophages impairs migration, reprograms metabolism, and limits tumor progression. Int J Biol Sci 22:2754-2773 

     
  • Gancino Guevara MA, Kardani A, Schomisch A, Rasheed S, Mashayekhi V, Saccon E, Abdukarimov N, Kirilov NK, Junker S, Weiss AV, Koch M, Gasparoni G, Schneider M, Schulze-Hentrich J, Bischoff M, Becker SL, Müller R, Yildiz D, Fuhrmann G, Staufer O, Hoppstädter J, Kiemer AK. 2026. Extracellular vesicles derived from Enterococcus faecalis: inflammatory activation does not require internalization. Cell Commun Signal 10.1186/s12964-026-02926-9

     
  • Do HTT, Both S, Kröhler T, Pirritano M, van Wonterghem E, Raab E, Ahne L, Franzenburg S, Ibrahim EM, Simon M, Biswas J, Helms V*, Kessler SM, Kiemer AK. 2026. HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets in vivo and links IMP2 to autophagy. NAR Mol Med doi: 10.1093/narmme/ugag034

     
  • Kroesen, MD, Wagmann L, Gehl, AL, Kiemer AK, Meyer MR. 2026 Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7. Arch Toxicol doi: 10.1007/s00204-026-04444-6

     
  • Berwanger A, Wagner K, Both S, Kany AM, Mazlom K, Anna K.H. Hirsch AKH, Kiemer AK, Empting M. 2026. Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2) Eur J Med Chem 307: 118624

     
  • Gies S, Pohlers M, Tanzer T, Ampofo E, Laschke MW, Schafer M, Kim YJ, Bohle RM, Solomayer EF, Wagner K, Empting, M, Kiemer AK, Walch-Rückheim B. 2026. Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner. Int J Cancer 158:3021.3037 

     
  • Nguyen TT, Hemmer J, Kiemer AK, Diesel B, Lee S. 2026. Biodynamers as prodrugs with controlled uptake and activity. J Control Release 390:114538